BIOMAT Database Logo BIOMAT Database Logo

Indapamide in the treatment of mild to moderate hypertension. 1984

D N Wadhawan

UI MeSH Term Description Entries
D006973 Hypertension Persistently high systemic arterial BLOOD PRESSURE. Based on multiple readings (BLOOD PRESSURE DETERMINATION), hypertension is currently defined as when SYSTOLIC PRESSURE is consistently greater than 140 mm Hg or when DIASTOLIC PRESSURE is consistently 90 mm Hg or more. Blood Pressure, High,Blood Pressures, High,High Blood Pressure,High Blood Pressures
D007190 Indapamide A benzamide-sulfonamide-indole derived DIURETIC that functions by inhibiting SODIUM CHLORIDE SYMPORTERS. Metindamide,S-1520,SE-1520,S 1520,S1520,SE 1520,SE1520
D008297 Male Males
D002986 Clinical Trials as Topic Works about pre-planned studies of the safety, efficacy, or optimum dosage schedule (if appropriate) of one or more diagnostic, therapeutic, or prophylactic drugs, devices, or techniques selected according to predetermined criteria of eligibility and observed for predefined evidence of favorable and unfavorable effects. This concept includes clinical trials conducted both in the U.S. and in other countries. Clinical Trial as Topic
D004232 Diuretics Agents that promote the excretion of urine through their effects on kidney function. Diuretic,Diuretic Effect,Diuretic Effects,Effect, Diuretic,Effects, Diuretic
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

D N Wadhawan
Combination Treatment with Sustained-Release Verapamil and Indapamide in the Treatment of Mild-to-Moderate Hypertension.
March 1996, American journal of therapeutics,
D N Wadhawan
Combination Treatment with Sustained-Release Verapamil and Indapamide in the Treatment of Mild-to-Moderate Hypertension.
July 1996, American journal of therapeutics,
D N Wadhawan
Efficacious response with lower dose indapamide therapy in the treatment of elderly patients with mild to moderate hypertension.
January 1995, Journal of clinical pharmacology,
D N Wadhawan
Multicenter dose-response study of the effect of indapamide in the treatment of patients with mild to moderate hypertension.
January 1983, Clinical therapeutics,
D N Wadhawan
Clinical Efficacy and Safety of Lower-Dose Indapamide Therapy in the Treatment of Patients with Mild to Moderate Hypertension.
June 1994, American journal of therapeutics,
D N Wadhawan
Conversion from 2.5 mg to 1.25 mg indapamide in patients with mild to moderate hypertension.
July 1995, The Journal of family practice,
D N Wadhawan
Tolerability and well-being with indapamide in the treatment of mild-moderate hypertension. An Italian multicenter study.
January 1988, The American journal of medicine,
D N Wadhawan
Evaluation of indapamide 1.25 mg once daily in elderly patients with mild to moderate hypertension.
April 1997, Journal of human hypertension,
D N Wadhawan
Considerations in the treatment of mild-to-moderate hypertension.
March 2001, Managed care interface,
D N Wadhawan
Nitrendipine in the treatment of mild to moderate hypertension.
January 1984, Journal of cardiovascular pharmacology,
Copied contents to your clipboard!